Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Aeterna Zentaris Inc (0UGB)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.00 0.00    0.00%
31/12 - Closed. Currency in CAD ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 0.00 - 0.00
Type:  Equity
Market:  United Kingdom
ISIN:  CA0079755017 
SEDOL:  BLB7170
Aeterna Zentaris 0.00 0.00 0.00%

Aeterna Zentaris Inc Company Profile

 
Get an in-depth profile of Aeterna Zentaris Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

12

Equity Type

DRC

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests in Canada, Switzerland, Ireland, Denmark, Germany, the United States, and internationally. Its lead product is Macrilen (macimorelin), an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of patients with adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as endocrinology and oncology indications; AEZS-150, a delayed clearance parathyroid hormone fusion polypeptide that is in preclinical trial for the treatment of chronic hypoparathyroidism; and AEZS-130 that is in preclinical trial for the treatment of amyotrophic lateral sclerosis. The company also has a license and research agreement with University of Wuerzburg to development, manufacture, and commercialization of AIM biologicals for the treatment of neuromyelitis optica spectrum disorder; and for pre-clinical development towards the potential treatment of Parkinson’s disease. In addition, it has a license agreement with Consilient Health Ltd. and NK MEDITECH Ltd. for the development and commercialization of macimorelin; a distribution and commercialization agreement with Er-Kim Pharmaceuticals Bulgaria Eood for the commercialization of macimorelin for the diagnosis of growth hormone deficiency in children and adults; as well as The University of Sheffield, the United Kingdom for the development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of chronic hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Toronto, Canada.

Contact Information

Address 222 Bay Street Suite 3000
PO Box 53 Toronto, M5K 1E7
Canada
Phone -
Fax -

Top Executives

Name Age Since Title
Dennis Turpin - 1999 Independent Director
Ulf R. Rapp - - Member of the Scientific Advisory Board
Marcel Verheij - - Member of the Scientific Advisory Board
Gerald Batist - - Member of the Scientific Advisory Board
Gilles R. Gagnon 70 2007 Independent Director
Hartmut Michel - - Member of the Scientific Advisory Board
Alan H. DeCherney - - Member of the Scientific Advisory Board
Frans M. J. Debruyne - - Member of the Scientific Advisory Board
Peter G. Edwards 63 2020 Independent Director
Klaus Paulini - 2019 President, CEO & Executive Director
Daniel Douglas Von Hoff 76 2005 Member of the Scientific Advisory Board
Klaus H. R. Diedrich - - Member of the Scientific Advisory Board
René Frydman - - Member of the Scientific Advisory Board
Carolyn S. Egbert - 2012 Independent Chair of the Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AEZS Comments

Write your thoughts about Aeterna Zentaris Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mathieu Fournier
Mathieu Fournier Mar 09, 2021 10:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will this go back up?
Ali Ebrahimi
Ali Ebrahimi Feb 23, 2021 9:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why?!
mike croix
mike croix Feb 10, 2021 18:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bloomberg business announced today "WHO has recommended the Oxford AEterna Zentaris vaccine for adults over 18"
Dheeraj Kumar
Dheeraj Kumar Feb 10, 2021 18:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
should we hold or short
mike croix
mike croix Feb 10, 2021 18:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why short?
Clrs Qwerty
Clrs Qwerty Feb 10, 2021 11:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy the dippp
Hassan Mahmood
Hassan Mahmood Feb 10, 2021 11:10
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is it still a good buy?
Jeremy Scott
Jeremy Scott Feb 08, 2021 15:50
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Probably back up to eighth within a week
Amar Raj
Amar Raj Feb 08, 2021 15:50
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sounds good
Amar Raj
Amar Raj Feb 08, 2021 15:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
anyone knows how up it will go
richard paquin
richard paquin Feb 08, 2021 15:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yes we have a crystal ball
Jeremy Scott
Jeremy Scott Feb 08, 2021 15:20
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Here we go zhold tight
Jeremy Scott
Jeremy Scott Feb 08, 2021 11:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good things are coming soon
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email